The9 investee Nanyang Biologics advances toward Nasdaq listing By Investing.com
The9 Limited announced that its Singapore investee Nanyang Biologics Pte. Ltd. has received notice of effectiveness from the U.S. SEC for its F-4 registration statement, moving it closer to a Nasdaq listing under the ticker "NYB." The business combination values Nanyang Biologics at approximately …